Leaflet HOLOXAN 1g powder infusion solution


Indicated for: cancer

Route of administration: infusion

Substance: ifosfamide (alkylating antineoplastic agent)

ATC: L01AA06 (Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues)

Ifosfamide is a chemotherapy medication used to treat various types of cancer, including sarcomas, lymphomas, and testicular cancer. It belongs to the class of alkylating agents and works by interfering with the DNA of cancer cells, thereby inhibiting their growth and division.

The medication is administered via intravenous infusion under the supervision of an oncologist.

Side effects may include nausea, vomiting, hair loss, decreased blood cell counts, or hemorrhagic cystitis. In rare cases, severe allergic reactions or kidney dysfunction may occur.

Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should not use this medication.

General data about HOLOXAN 1g

  • Substance: ifosfamide
  • Date of last drug list: 01-05-2026
  • Commercial code: W70295001
  • Concentration: 1g
  • Pharmaceutical form: powder infusion solution
  • Quantity: 1
  • Product type: original
  • Price: 178.15 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BAXTER ONCOLOGY GMBH - GERMANIA
  • Holder: BAXTER HEALTHCARE S.R.L. - ROMANIA
  • Number: 11919/2019/01
  • Shelf life: 5 years-after packaging for sale; after reconstituting the solution: 24 hours

Concentrations available for ifosfamide

  • 1g
  • 2g
  • 500mg

Compensation lists for HOLOXAN 1g Baxter

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

178.15 RON

178.15 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

178.15 RON

178.15 RON

0.00 RON